173 related articles for article (PubMed ID: 26807135)
1. The role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sickness.
Kato CD; Matovu E; Mugasa CM; Nanteza A; Alibu VP
Allergy Asthma Clin Immunol; 2016; 12():4. PubMed ID: 26807135
[TBL] [Abstract][Full Text] [Related]
2. Interleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness.
Kato CD; Alibu VP; Nanteza A; Mugasa CM; Matovu E
PLoS Negl Trop Dis; 2015 Jun; 9(6):e0003835. PubMed ID: 26090964
[TBL] [Abstract][Full Text] [Related]
3. Investigation of thiazolyl-benzothiophenamides as potential agents for African sleeping sickness.
Brown RW; Abdel-Megeed AM; Keller PA; Jones AJ; Sykes ML; Kaiser M; Baell JB; Avery VM; Hyland CJT
RSC Med Chem; 2020 Dec; 11(12):1413-1422. PubMed ID: 34095848
[TBL] [Abstract][Full Text] [Related]
4. The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History.
P De Koning H
Trop Med Infect Dis; 2020 Jan; 5(1):. PubMed ID: 31963784
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil metalloproteinase driven spleen damage hampers infection control of trypanosomiasis.
Pham HTT; Magez S; Choi B; Baatar B; Jung J; Radwanska M
Nat Commun; 2023 Sep; 14(1):5418. PubMed ID: 37669943
[TBL] [Abstract][Full Text] [Related]
6. How a Nigerian biochemist hopes to stop the spread of sleeping-sickness disease.
Tsanni A
Nature; 2019 May; ():. PubMed ID: 32398815
[No Abstract] [Full Text] [Related]
7. Immune Evasion Strategies of Trypanosoma brucei within the Mammalian Host: Progression to Pathogenicity.
Stijlemans B; Caljon G; Van Den Abbeele J; Van Ginderachter JA; Magez S; De Trez C
Front Immunol; 2016; 7():233. PubMed ID: 27446070
[TBL] [Abstract][Full Text] [Related]
8. Population genomics reveals the origin and asexual evolution of human infective trypanosomes.
Weir W; Capewell P; Foth B; Clucas C; Pountain A; Steketee P; Veitch N; Koffi M; De Meeûs T; Kaboré J; Camara M; Cooper A; Tait A; Jamonneau V; Bucheton B; Berriman M; MacLeod A
Elife; 2016 Jan; 5():e11473. PubMed ID: 26809473
[TBL] [Abstract][Full Text] [Related]
9. Species-Specific Adaptations of Trypanosome Morphology and Motility to the Mammalian Host.
Bargul JL; Jung J; McOdimba FA; Omogo CO; Adung'a VO; Krüger T; Masiga DK; Engstler M
PLoS Pathog; 2016 Feb; 12(2):e1005448. PubMed ID: 26871910
[TBL] [Abstract][Full Text] [Related]
10. 3D Architecture of the Trypanosoma brucei Flagella Connector, a Mobile Transmembrane Junction.
Höög JL; Lacomble S; Bouchet-Marquis C; Briggs L; Park K; Hoenger A; Gull K
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004312. PubMed ID: 26820516
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis.
Kennedy PGE; Rodgers J
Front Immunol; 2019; 10():39. PubMed ID: 30740102
[TBL] [Abstract][Full Text] [Related]
12. Ginkgo biloba attenuated detrimental inflammatory and oxidative events due to Trypanosoma brucei rhodesiense in mice treated with melarsoprol.
Wendo JK; Mbaria JM; Nyariki JN; Isaac AO
PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012103. PubMed ID: 38620045
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory potential of Sarcophaga argyostoma larval hemolymph as a natural alternative to berenil in treating Trypanosoma evansi in vivo.
Sadek AM; Farghaly DS; Kadada H; Mashaal A
Sci Rep; 2024 Mar; 14(1):6972. PubMed ID: 38521853
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme Q
Kitwan L; Makobe C; Mdachi R; Maranga DN; Isaac AO; Nyariki JN
J Parasit Dis; 2023 Mar; 47(1):167-184. PubMed ID: 36910316
[TBL] [Abstract][Full Text] [Related]
15. Plasma Neuron-Specific Enolase is not a reliable biomarker for staging Trypanosoma brucei rhodesiense sleeping sickness patients.
Kato CD; Twesigye D; Alibu VP; Nanteza A; Nsubuga J; Mugasa CM; Matovu E
BMC Res Notes; 2022 Mar; 15(1):97. PubMed ID: 35255971
[TBL] [Abstract][Full Text] [Related]
16. A Preliminary Study on the Relationship between Parasitaemia and Cytokine Expression of Peripheral Blood Cells in
Fidelis Junior OL; Sampaio PH; Gonçalves LR; Machado RZ; André MR; Wijffels G; Cadioli FA
Animals (Basel); 2021 Nov; 11(11):. PubMed ID: 34827923
[No Abstract] [Full Text] [Related]
17. Microarray profiling predicts early neurological and immune phenotypic traits in advance of CNS disease during disease progression in Trypanosoma. b. brucei infected CD1 mouse brains.
Montague P; Bradley B; Rodgers J; Kennedy PGE
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009892. PubMed ID: 34762691
[TBL] [Abstract][Full Text] [Related]
18. Mouse experiments demonstrate differential pathogenicity and virulence of Trypanosoma brucei rhodesiense strains.
Kipkorir LW; John TK; Owino OB; John O; Robert S; Daniel M; Owino AV
Exp Parasitol; 2021 Sep; 228():108135. PubMed ID: 34284027
[TBL] [Abstract][Full Text] [Related]
19. Role of the inhibitor of serine peptidase 2 (ISP2) of Trypanosoma brucei rhodesiense in parasite virulence and modulation of the inflammatory responses of the host.
Levy DJ; Goundry A; Laires RSS; Costa TFR; Novo CM; Grab DJ; Mottram JC; Lima APCA
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009526. PubMed ID: 34153047
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
